Filter by: Subject

Filter by: Subject

Results Per Page:

Tuberculosis (TB) (28)
Mycobacterium tuberculosis (MTB) (17)
South Africa (SA) (14)
Bedaquiline (10)
Drug resistance (7)
Multidrug-resistant tuberculosis (MDR-TB) (7)
Drug-resistant tuberculosis (DR-TB) (6)
Human immunodeficiency virus (HIV) (6)
Drug susceptibility testing (DST) (5)
Extensively drug-resistant tuberculosis (XDR-TB) (5)
Mycobacterium tuberculosis (5)
Clofazimine (4)
Clofazimine (CFZ) (3)
Multidrug-resistant (MDR) (3)
Rifampicin-resistant tuberculosis (3)
South Africa (3)
Adults (2)
Anti-infective agents -- South Africa (2)
Antiretroviral therapy (ART) (2)
Bacteria (2)
Drug-resistant tuberculosis (2)
Epidemics (2)
Genome (2)
Infection (2)
KwaZulu-Natal, South Africa (2)
Linezolid (2)
Loss to follow-up (LTFU) (2)
MDR-TB (2)
Minimum inhibitory concentrations (MIC) (2)
Molecular detection (2)
Mutation (2)
Patients (2)
Quality control (QC) (2)
SDG-03: Good health and well-being (2)
Transmission (2)
Tuberculosis transmission (2)
Whole genome sequencing (WGS) (2)
XDR-TB (2)
24-loci MIRU-VNTR typing (1)
960™ (1)
Abbott RealTime MTB (1)
Acid-fast bacilli (AFB) (1)
Acquired immune deficiency syndrome (AIDS) (1)
Activity space (1)
Africa (1)
Anti-tuberculosis drugs (1)
Antibiotic-resistant (1)
Antimicrobial resistance (1)
Antimicrobial resistance (AMR) (1)
Antimycobacterials (1)
Antituberculosis therapy (1)
Area under the curve (1)
Assays (1)
AtpE mutations (1)
BACTEC MGIT 960 (1)
Bacteraemia (1)
Bedaquiline (BDQ) (1)
Bias analysis (1)
Biological marker (1)
Broth micro-dilution assay (BMD) (1)